Niels Borgstein

819 total citations
21 papers, 594 citations indexed

About

Niels Borgstein is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Niels Borgstein has authored 21 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Gastroenterology and 4 papers in Surgery. Recurrent topics in Niels Borgstein's work include Prostate Cancer Treatment and Research (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Gastrointestinal motility and disorders (4 papers). Niels Borgstein is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Gastrointestinal motility and disorders (4 papers). Niels Borgstein collaborates with scholars based in United States, Netherlands and France. Niels Borgstein's co-authors include Matthew L. Sherman, Yijun Yang, Dawn Wilson, Rien J.M. Nijman, Pamela Ellsworth, Amelia E. Pearsall, Kenneth M. Attie, Carolyn H. Condon, Ravi Kumar and Jens C. Djurhuus and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Niels Borgstein

21 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niels Borgstein United States 12 180 175 120 94 89 21 594
Erik Enquist United States 10 182 1.0× 188 1.1× 44 0.4× 34 0.4× 48 0.5× 13 665
Francisco Pina Portugal 12 177 1.0× 354 2.0× 104 0.9× 57 0.6× 89 1.0× 34 680
Dilek Ertoy Türkiye 16 231 1.3× 187 1.1× 34 0.3× 36 0.4× 20 0.2× 33 677
Burak Bahadır Türkiye 18 142 0.8× 113 0.6× 27 0.2× 14 0.1× 18 0.2× 42 641
Yuko Shima Japan 19 428 2.4× 211 1.2× 51 0.4× 4 0.0× 106 1.2× 61 1.2k
G. A. Müller Germany 12 216 1.2× 78 0.4× 27 0.2× 25 0.3× 21 0.2× 20 724
Irene Resch Austria 13 66 0.4× 235 1.3× 27 0.2× 56 0.6× 36 0.4× 33 634
Maurizio Poggi Italy 14 81 0.5× 68 0.4× 19 0.2× 15 0.2× 14 0.2× 37 675
Müge Akmansu Türkiye 15 108 0.6× 237 1.4× 127 1.1× 5 0.1× 31 0.3× 66 733
Tania Polhill Australia 12 298 1.7× 48 0.3× 27 0.2× 13 0.1× 34 0.4× 13 611

Countries citing papers authored by Niels Borgstein

Since Specialization
Citations

This map shows the geographic impact of Niels Borgstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niels Borgstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niels Borgstein more than expected).

Fields of papers citing papers by Niels Borgstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niels Borgstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niels Borgstein. The network helps show where Niels Borgstein may publish in the future.

Co-authorship network of co-authors of Niels Borgstein

This figure shows the co-authorship network connecting the top 25 collaborators of Niels Borgstein. A scholar is included among the top collaborators of Niels Borgstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niels Borgstein. Niels Borgstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Lin, Brian E. Lacy, Baha Moshiree, et al.. (2021). Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System. The American Journal of Gastroenterology. 116(9). 1929–1937. 32 indexed citations
2.
Chey, William D., Gregory S. Sayuk, Wilmin Bartolini, et al.. (2020). Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation. The American Journal of Gastroenterology. 116(2). 354–361. 17 indexed citations
3.
Nurko, Samuel, Jeffrey S. Hyams, Niels Borgstein, et al.. (2020). 911 LINACLOTIDE SAFETY AND EFFICACY IN CHILDREN AGED 7 TO 17 YEARS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION. Gastroenterology. 158(6). S–182. 1 indexed citations
4.
Nurko, Samuel, et al.. (2019). 1151 Linaclotide Safety and Efficacy in Children Aged 6 to 17 Years With Functional Constipation. The American Journal of Gastroenterology. 114(1). S645–S646. 8 indexed citations
6.
Beer, Tomasz M., Nicholas J. Vogelzang, Jiřina Bartůňková, et al.. (2015). Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P164–P164. 5 indexed citations
8.
Vogelzang, Nicholas J., Tomasz M. Beer, Jiřina Bartůňková, et al.. (2015). Autologous dendritic cell vaccination (DCVAC/PCa) added to docetaxel chemotherapy in a double-blind, randomized phase III trial (VIABLE) in men with advanced (mCRPC) prostate cancer.. Journal of Clinical Oncology. 33(15_suppl). TPS5070–TPS5070. 4 indexed citations
12.
Wit, Ronald de, Karim Fizazi, Viorel Jinga, et al.. (2014). Phase 3, randomized, placebo-controlled trial of orteronel (TAK-700) plus prednisone in patients (pts) with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) (ELM-PC 4 trial). Journal of Clinical Oncology. 32(15_suppl). 5008–5008. 18 indexed citations
13.
Sherman, Matthew L., Niels Borgstein, Dawn Wilson, et al.. (2013). Multiple‐dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA‐IgG1), a novel erythropoietic agent, in healthy postmenopausal women. The Journal of Clinical Pharmacology. 53(11). 1121–1130. 86 indexed citations
14.
Attie, Kenneth M., Niels Borgstein, Yijun Yang, et al.. (2012). A single ascending‐dose study of muscle regulator ace‐031 in healthy volunteers. Muscle & Nerve. 47(3). 416–423. 144 indexed citations
16.
Reddy, Pramod, Niels Borgstein, Rien J.M. Nijman, & Pamela Ellsworth. (2008). Long-term efficacy and safety of tolterodine in children with neurogenic detrusor overactivity. Journal of Pediatric Urology. 4(6). 428–433. 23 indexed citations
18.
Nijman, Rien J.M., Niels Borgstein, Pamela Ellsworth, & Charlotte Siggaard. (2007). Long-Term Tolerability of Tolterodine Extended Release in Children 5–11 Years of Age: Results from a 12-Month, Open-Label Study. European Urology. 52(5). 1511–1517. 18 indexed citations
19.
Ellsworth, Pamela, Niels Borgstein, Rien J.M. Nijman, & Pramod Reddy. (2005). USE OF TOLTERODINE IN CHILDREN WITH NEUROGENIC DETRUSOR OVERACTIVITY: RELATIONSHIP BETWEEN DOSE AND URODYNAMIC RESPONSE. The Journal of Urology. 174(4 Part 2). 1647–1651. 14 indexed citations
20.
Nijman, Rien J.M., Niels Borgstein, Pamela Ellsworth, & Jens C. Djurhuus. (2005). TOLTERODINE TREATMENT FOR CHILDREN WITH SYMPTOMS OF URINARY URGE INCONTINENCE SUGGESTIVE OF DETRUSOR OVERACTIVITY: RESULTS FROM 2 RANDOMIZED, PLACEBO CONTROLLED TRIALS. The Journal of Urology. 173(4). 1334–1339. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026